Skip to main content
GutCited

Vitamin D Inflammatory Bowel Disease (IBD) — General

B

Supplementation (1,000-4,000 IU/day) reduces relapse risk in both UC and Crohn's. Deficiency is common in IBD (up to 60%) and correlates with disease severity.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dvitamin\u002Dd\u0026condition\u003Dinflammatory\u002Dbowel\u002Ddisease'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

結論

Supplementation (1,000-4,000 IU/day) reduces relapse risk in both UC and Crohn's. Deficiency is common in IBD (up to 60%) and correlates with disease severity.

Key Study Findings

Review
Early Evidence Indicates Vitamin D Improves Symptoms of Irritable Bowel Syndrome: Nursing Implications and Future …
Dose: None vs: None Outcome: IBS symptom improvement with vitamin D supplementation 効果: None None

対象集団: individuals with irritable bowel syndrome

Review
Diet in Ulcerative Colitis: A Narrative Review of Its Role in Pathogenesis and Treatment.
Dose: None vs: None Outcome: None 効果: None None

対象集団: patients with ulcerative colitis

Review
Probiotics in inflammatory bowel disease: microbial modulation and therapeutic prospects.
Dose: None vs: None Outcome: None 効果: None None

対象集団: review of probiotics as therapeutic strategy for inflammatory bowel disease

Review
Micronutrient Deficiencies in Pediatric IBD: How Often, Why, and What to Do?
Dose: None vs: None Outcome: Micronutrient deficiency management in pediatric IBD 効果: None None

対象集団: Children with inflammatory bowel disease (review)

Observational Study n=193
The importance of vitamin D levels in patients with inflammatory bowel disease.
Dose: None vs: Clinical activity groups and VD status groups Outcome: Vitamin D levels and IBD activity markers 効果: None 0.009 (CD), 0.033 (UC), 0.032

対象集団: Greek IBD patients (122 CD, 71 UC)

Review
Osteoporosis: A Review.
Dose: None vs: None Outcome: None 効果: None None

対象集団: Adults with osteoporosis

Key Statistics

10

研究数

1500

参加者数

Positive

B

グレード

Referenced Papers

JAMA 2025
Swiss medical weekly 2024 9 件の引用
Nutricion hospitalaria 2024 2 件の引用
Paediatrics and international … 2023 48 件の引用
Archives of Iranian … 2023 2 件の引用
The Cochrane database … 2023 1 件の引用
Endocrine connections 2022 50 件の引用
Journal of inflammation … 2022 50 件の引用
Autoimmunity reviews 2022 44 件の引用
Frontiers in bioscience … 2022 17 件の引用
European journal of … 2021 40 件の引用
Autoimmunity reviews 2020 48 件の引用
Acta biochimica Polonica 2020 10 件の引用
The Korean journal … 2020 3 件の引用
Revista espanola de … 2020 2 件の引用
Frontline gastroenterology 2019 58 件の引用
Critical reviews in … 2019 45 件の引用
Complementary therapies in … 2019 27 件の引用
Current opinion in … 2019 5 件の引用
Current opinion in … 2018 94 件の引用
Gastroenterology clinics of … 2018 67 件の引用
Journal of research … 2018 48 件の引用
Gastroenterology 2017 335 件の引用
Nutrition in clinical … 2017 55 件の引用
World journal of … 2016 238 件の引用
Current gastroenterology reports 2016 22 件の引用
Journal of medicinal … 2016 17 件の引用
Gastroenterology & hepatology 2016 7 件の引用
BioMed research international 2015 149 件の引用
World journal of … 2015 62 件の引用
Healthcare (Basel, Switzerland) 2015 7 件の引用
Journal of inflammation … 2014 411 件の引用
Experimental biology and … 2014 131 件の引用
Inflammatory bowel diseases 2012 224 件の引用
Vitamins and hormones 2011 25 件の引用
Current opinion in … 2011 23 件の引用
Joint bone spine 2010 281 件の引用
Acta medica Indonesiana 2007 4 件の引用
Nature clinical practice. … 2005 191 件の引用
Alimentary pharmacology & … 2003 179 件の引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
600-800 IU/day (RDA)
ibdsupport:
1,000-4,000 IU/day (target serum 25(OH)D >30 ng/mL)
deficiencycorrection:
50,000 IU/week for 8 weeks, then 1,000-4,000 IU/day maintenance

上限量: 4,000 IU/day (100 mcg); higher doses under medical supervision only

研究で検討された用量

用量 期間 効果 N
None -- Positive --
None -- Mixed --
None -- Positive --
None -- Neutral --
None -- Negative 193
None -- Mixed --
None 690 weeks Neutral 357656
None -- Positive 310

推奨摂取タイミング: With a meal containing fat for better absorption

Safety & Side Effects

報告されている副作用

  • Hypercalcemia at very high doses (nausea, vomiting, weakness, confusion)
  • Kidney stones with excessive long-term supplementation
  • Constipation
  • Metallic taste

既知の相互作用

  • Thiazide diuretics (may increase risk of hypercalcemia)
  • Corticosteroids (reduce vitamin D absorption and metabolism)
  • Orlistat and cholestyramine (reduce fat-soluble vitamin absorption)
  • Statins (vitamin D may affect statin metabolism)

耐容上限摂取量: 4,000 IU/day (100 mcg); higher doses under medical supervision only

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does Vitamin D help with Inflammatory Bowel Disease (IBD) — General?
Based on 10 studies with 1,500 participants, there is moderate evidence from clinical studies that Vitamin D may support Inflammatory Bowel Disease (IBD) — General management. Our evidence grade is B (Good Evidence).
How much Vitamin D should I take for Inflammatory Bowel Disease (IBD) — General?
Studies have used various dosages. A commonly studied range is 600-800 IU/day (RDA). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin D?
Reported side effects may include Hypercalcemia at very high doses (nausea, vomiting, weakness, confusion), Kidney stones with excessive long-term supplementation, Constipation, Metallic taste. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin D and Inflammatory Bowel Disease (IBD) — General?
We rate the evidence as Grade B (Good Evidence). This rating is based on 10 peer-reviewed studies with 1,500 total participants. The overall direction of effect is positive.

Related Evidence

に関する他の成分: Inflammatory Bowel Disease (IBD) — General

Vitamin D 他の症状・状態について

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。